 hepatotox rifampin isoniazid drug-induc hepat serolog marker hepat virus children acut hepat antituberculosi therapi rifampin isoniazid aim contributori role virus hepat injuri patient igm antibodi epidemiolog evid possibl non-a non-b hepat children hepat children sever tubercular diseas studi highlight endem viral hepat countri factor respons incid hepatotox countri risk hepatotox sever tubercular diseas